Overview
Unused medication worth billions of dollars in ends up in the trash every year. For example, research shows medication worth over $3 billion is thrown out by hospitals every year, and an additional $2 billion worth is discarded in long-term care facilities. Medication in these settings often goes unused because a patient’s condition improves, they change doses, change care settings or die. Any unopened medicine not used by the patient must be disposed of.
Instead of disposing of the unused medicine, facilities in states with repository programs may donate it. By collecting unused prescription drugs and redistributing them to qualifying individuals, prescription drug donation and reuse programs, or drug repositories, aim to increase medication access, especially to underserved populations.
As of September 2023, 44 states, Washington D.C., and Guam, have laws establishing prescription drug repository programs. Twenty-eight states have operational programs, with three more expected to be operational within the next year. Eighteen states, Guam, and Washington D.C. have laws enacted but are not operational. Operational programs are those with participating pharmacies, charitable clinics or hospitals approved by the state to collect and redistribute donated drugs.
Most state laws also permit the donation of cancer drugs within their existing drug repository programs. In addition to their general drug repository program, Florida, Michigan and Montana, also have a separate repository program specific for cancer drugs.
Comprehensive state donation and redistribution programs may help expand access to affordable drugs for patients across the country. Existing programs have had significant success in helping people afford the prescriptions they need to remain healthy, but barriers exist that prevent many operational and non-operational programs from reaching their full potential, including:
- Administrative and operational burdens on participating entities.
- Inadequate financial resources and funding.
- Lack of public awareness of existing programs.
- Limited donor and recipient organization eligibility.
- Restrictive patient eligibility.
- Inadequate interstate collaboration.